S100鈣結(jié)合蛋白(S100)單克隆抗體
Monoclonal Antibody to S100 Calcium Binding Protein (S100)
S100-A1; S100A1; S100-Alpha; S-100 Protein; S-100 protein subunit alpha; S-100 protein alpha chain
- 編號MAA012Hu21
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)C2
- Ig亞型 IgG1 Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標記物無標記物
- 免疫原 RPA012Hu01-S100鈣結(jié)合蛋白(S100)重組蛋白
- 緩沖液成份磷酸鹽緩沖液(pH7.4,含有0.02% NaN3和50%甘油)
- 性狀液體
- 濃度1mg/ml
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術(shù),請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 630 ¥ 1470 ¥ 2100 ¥ 5250 ¥ 21000
- 欲了解實際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
特異性
該抗體是針對S100的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別S100。
用法
Western blotting: 0.01-2μg/mL
Immunohistochemistry: 5-20μg/mL
Immunocytochemistry: 5-20μg/mL
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
EPA012Hu61 | S100鈣結(jié)合蛋白(S100)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA012Hu01 | S100鈣結(jié)合蛋白(S100)活性蛋白 | Cell?culture;?Activity?Assays. |
RPA012Hu01 | S100鈣結(jié)合蛋白(S100)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA012Hu61 | S100鈣結(jié)合蛋白(S100)活性蛋白 | Cell?culture;?Activity?Assays. |
PAA012Hu02 | S100鈣結(jié)合蛋白(S100)多克隆抗體 | WB; IHC; ICC; IP. |
PAA012Hu01 | S100鈣結(jié)合蛋白(S100)多克隆抗體 | WB; IHC; ICC; IP. |
LAA012Hu71 | S100鈣結(jié)合蛋白(S100)多克隆抗體(生物素標記) | WB; IHC; ICC. |
LAA012Hu81 | S100鈣結(jié)合蛋白(S100)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
MAA012Hu23 | S100鈣結(jié)合蛋白(S100)單克隆抗體 | WB; IHC; ICC; IP. |
MAA012Hu24 | S100鈣結(jié)合蛋白(S100)單克隆抗體 | WB; IHC; ICC; IP. |
MAA012Hu27 | S100鈣結(jié)合蛋白(S100)單克隆抗體 | WB; IHC; ICC; IP. |
MAA012Hu21 | S100鈣結(jié)合蛋白(S100)單克隆抗體 | WB; IHC; ICC; IP. |
MAA012Hu25 | S100鈣結(jié)合蛋白(S100)單克隆抗體 | WB; IHC; ICC; IP. |
MAA012Hu22 | S100鈣結(jié)合蛋白(S100)單克隆抗體 | WB; IHC; ICC; IP. |
MAA012Hu29 | S100鈣結(jié)合蛋白(S100)單克隆抗體 | WB; IHC; ICC; IP. |
FAA012Hu02 | 抗S100鈣結(jié)合蛋白(S100)單克隆抗體 | FCM |
FAA012Hu04 | 抗S100鈣結(jié)合蛋白(S100)單克隆抗體 | FCM |
FAA012Hu06 | 抗S100鈣結(jié)合蛋白(S100)單克隆抗體 | FCM |
SEA012Hu | S100鈣結(jié)合蛋白(S100)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
AEA012Hu | 抗S100鈣結(jié)合蛋白抗體(Anti-S100)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antibody Detection. |
SCA012Hu | S100鈣結(jié)合蛋白(S100)檢測試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
PSA012Hu01 | S100鈣結(jié)合蛋白(S100)抗體對 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
KSA012Hu01 | S100鈣結(jié)合蛋白(S100)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
雜志 | 參考文獻 |
Brain Research | Vasoactive intestinal peptide protects against ischemic brain damage induced by focal cerebral ischemia in rats [ScienceDirect: S0006899311008663] |
J Exp Neurosci | A New Technique for Collection of Cerebrospinal Fluid in Rat Pups [PubMed: 26056488] |
PLoS One | Regulation of Nutritional Metabolism in Transition Dairy Cows: Energy Homeostasis and Health in Response to Post-Ruminal Choline and Methionine [pubmed:27501393] |
brain research | Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease: Possible involvement of ERβ/Nrf2/HO-1 signaling. [pubmed:28238669] |
КиберЛенинка | Levels of neurotropic autoantibodies in patients with schizophrenia [article:n] |
Biomed?Research International | Epigallocatechin-3-Gallate Reduces Neuronal Apoptosis in Rats after Middle Cerebral Artery Occlusion Injury via PI3K/AKT/eNOS Signaling Pathway [Pubmed:29770336] |
Metabolic?Brain?Disease | Trigonelline protects hippocampus against intracerebral Aβ (1–40) as a model of Alzheimer's disease in the rat: insights into underlying mechanisms [Pubmed: 30421246] |
ВОЗМОЖНОСТЬ ПРОГНОЗИРОВАНИЯ ОСТРОЙ НЕСПЕЦИФИЧЕСКОЙ БОЛИ В НИЖНЕЙ ЧАСТИ СПИНЫ С ИСПОЛЬЗОВАНИЕМ СЫВОРОТОЧНЫХ?… [] | |
ВЛИЯНИЕ ХРОНИЧЕСКОГО ВВЕДЕНИЯ НЕЙРОЛЕПТИКОВ НА УРОВНИ НЕЙРОСПЕЦИФИЧЕСКИХ АУТОАНТИТЕЛ В КРОВИ У КРЫС [] |
留言咨詢